Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Human Neuroscience|August 3, 2023
Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settingsNicolas Garel, Julien Thibault Lévesque, Dasha A Sandra, et al.
International Journal of Psychiatry in Clinical Practice|December 4, 2020
Psychological pain and depression: it's hard to speak when it hurtsStéphane Richard-Devantoy, Josie-Anne Bertrand, Séverine Béziat, et al.
Neuroscience of Consciousness|June 8, 2026
Computational spirits: a neuroscientific account of psychedelic entity encountersJonas Mago, George Deane, Lars Sandved-Smith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 2, 2023
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary reportNicolas Garel, Kyle T Greenway, Lê-Anh L Dinh-Williams, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 5, 2026
A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patientsMichka Nazon, Paola Lavin, C William Pike, et al.
Frontiers in Neurology|December 31, 2021
A Systematic Review of Telemedicine for Older Adults With Dementia During COVID-19: An Alternative to In-person Health Services?Sasha Elbaz, Karin Cinalioglu, Kerman Sekhon, et al.
Frontiers in Psychiatry|October 5, 2023
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depressionNicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Scientific Reports|July 17, 2024
Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapySara de la Salle, Hannes Kettner, Julien Thibault Lévesque, et al.
Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 18, 2025
The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depressionKyle T Greenway, Nicolas Garel, Lê-Anh L Dinh-Williams, et al.
Pageof 4